Real-time SEC alerts Start Free →
Profitelligence
Dexcom Inc.
DXCM MEDIUM Impact

Dexcom Inc.

DexCom, Inc. Announces Voting Results from 2024 Annual Meeting of Stockholders

| 8-K |Healthcare

Summary

DexCom, Inc. held its 2024 Annual Meeting of Stockholders on May 22, 2024. All ten nominees for the board of directors were elected with significant support. Shareholders ratified the selection of Ernst & Young LLP as the independent registered public accounting firm. An advisory vote approved the compensation of named executive officers, while a proposal for pay equity disclosure and a proposal for transparency in lobbying were not approved. Final vote counts for each proposal are provided in the filing.

Profitelligence Profitelligence Alerts

Get alerts for DXCM

Be first to know when Dexcom Inc. files with the SEC.

Set Up Alerts →

Filing Categories

Director Elections Results Say-on-Pay Approved Say-on-Pay Failed

Advertisement

About Dexcom Inc.

Dexcom Inc. is a prominent player in the medical technology sector, specializing in continuous glucose monitoring (CGM) systems for diabetes management. The company's primary function is to develop and distribute innovative CGM devices that provide real-time glucose readings, allowing individuals with diabetes to make informed decisions about their health. Dexcom’s products play a critical role in healthcare by offering an alternative to traditional fingerstick testing, thus improving quality of life for many users. The company impacts several sectors, most notably within healthcare and technology, by integrating advanced data analytics and wireless technology into its monitoring systems. This not only aids individuals in managing their glucose levels but also supports healthcare providers in delivering better patient care through data-driven insights. In the financial market, Dexcom Inc. is recognized for its contributions to the growing field of digital health solutions. The company has established itself as a leader in its niche, continuously pushing the boundaries of technology to offer more precise and user-friendly glucose monitoring options. Founded in 1999 and headquartered in San Diego, California, Dexcom remains at the forefront of diabetes management solutions.

Exchange: NASDAQ Industry: Medical Devices Company Website →

Official SEC Documents

DXCM
DXCM Research
8Ks, insider trades, financials, technicals
SEC Alert Manager
Get alerts within 60 seconds of new filings

Advertisement